D. E. Shaw & Co., Inc. - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$619,407
-92.7%
6,075
-93.5%
0.00%
-88.9%
Q1 2023$8,493,383
-30.5%
93,416
-71.0%
0.01%
-35.7%
Q4 2022$12,228,335
+193.5%
321,883
+94.1%
0.01%
+180.0%
Q3 2022$4,167,000
-47.2%
165,830
-36.1%
0.01%
-44.4%
Q2 2022$7,891,000
+331.0%
259,655
+364.6%
0.01%
+350.0%
Q1 2022$1,831,000
+19.4%
55,890
-3.9%
0.00%
+100.0%
Q4 2021$1,533,000
+27.0%
58,129
+384.4%
0.00%0.0%
Q3 2021$1,207,000
+116.7%
12,000
+109.8%
0.00%0.0%
Q3 2020$557,000
-95.1%
5,720
-92.2%
0.00%
-92.9%
Q2 2020$11,475,000
+85.9%
73,545
+72.0%
0.01%
+40.0%
Q1 2020$6,173,000
+202.0%
42,765
+327.6%
0.01%
+400.0%
Q4 2019$2,044,000
+492.5%
10,000
+132.6%
0.00%
Q3 2019$345,000
-40.1%
4,300
-29.5%
0.00%
-100.0%
Q2 2019$576,000
-72.3%
6,100
-74.9%
0.00%
-66.7%
Q1 2019$2,079,000
-5.5%
24,329
-37.9%
0.00%0.0%
Q4 2018$2,199,000
-41.6%
39,196
-14.8%
0.00%
-40.0%
Q3 2018$3,763,00046,0190.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders